Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of its kind and marks a turning point in the ...

Explore findings from a clinical trial revealing how interruptive decision support systems enhance suicide risk assessments ...

The trial, developed in collaboration with Novotech, will specifically target dietary and alcohol-induced overindulgence.

Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...

Sanford Health is teaming up with Medtronic to test a procedure aimed at reducing medication dependency for high blood ...

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

Stuart Therapeutics completed a Phase 3 trial for ST-100, a treatment for dry eye disease, involving a randomized, ...

Protocol AI accelerates clinical trial development and patient access to medical devices BERN, Switzerland , Jan. 22, 2025 /PRNewswire/ -- Risklick, a spin-off from the University of Bern ...